John Overdeck’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-80,397
| Closed | -$22K | – | 3213 |
|
|
2022
Q3 | $22K | Buy |
+80,397
| New | +$35.1K | ﹤0.01% | 2376 |
|
|
2022
Q1 | – | Sell |
-87,374
| Closed | -$166K | – | 4735 |
|
|
2021
Q4 | $166K | Buy |
87,374
+38,196
| +78% | +$91.5K | ﹤0.01% | 3972 |
|
|
2021
Q3 | $148K | Buy |
49,178
+25,998
| +112% | +$92.6K | ﹤0.01% | 4027 |
|
|
2021
Q2 | $91K | Buy |
23,180
+12,894
| +125% | +$53.5K | ﹤0.01% | 3911 |
|
|
2021
Q1 | $52K | Sell |
10,286
-139,354
| -93% | -$723K | ﹤0.01% | 3740 |
|
|
2020
Q4 | $612K | Buy |
149,640
+113,279
| +312% | +$556K | ﹤0.01% | 2357 |
|
|
2020
Q3 | $177K | Sell |
36,361
-83,438
| -70% | -$456K | ﹤0.01% | 2846 |
|
|
2020
Q2 | $664K | Buy |
119,799
+6,847
| +6% | +$31.4K | ﹤0.01% | 1804 |
|
|
2020
Q1 | $370K | Buy |
112,952
+47,781
| +73% | +$252K | ﹤0.01% | 2152 |
|
|
2019
Q4 | $295K | Sell |
65,171
-5,295
| -8% | -$16.7K | ﹤0.01% | 3198 |
|
|
2019
Q3 | $293K | Sell |
70,466
-36,501
| -34% | -$132K | ﹤0.01% | 2980 |
|
|
2019
Q2 | $405K | Sell |
106,967
-33,516
| -24% | -$137K | ﹤0.01% | 2656 |
|
|
2019
Q1 | $589K | Sell |
140,483
-66,039
| -32% | -$231K | ﹤0.01% | 2174 |
|
|
2018
Q4 | $514K | Buy |
206,522
+81,250
| +65% | +$476K | ﹤0.01% | 2084 |
|
|
2018
Q3 | $914K | Buy |
125,272
+92,780
| +286% | +$406K | ﹤0.01% | 2042 |
|
|
2018
Q2 | $120K | Buy |
+32,492
| New | +$150K | ﹤0.01% | 3193 |
|
|
2018
Q1 | – | Sell |
-60,892
| Closed | -$219K | – | 3637 |
|
|
2017
Q4 | $219K | Buy |
60,892
+14,011
| +30% | +$52.9K | ﹤0.01% | 2884 |
|
|
2017
Q3 | $185K | Buy |
46,881
+25,695
| +121% | +$118K | ﹤0.01% | 2602 |
|
|
2017
Q2 | $108K | Buy |
+21,186
| New | +$119K | ﹤0.01% | 2864 |
|
|
2016
Q4 | – | Sell |
-19,090
| Closed | -$187K | – | 3616 |
|
|
2016
Q3 | $187K | Buy |
+19,090
| New | +$258K | ﹤0.01% | 2970 |
|
|
2016
Q1 | – | Sell |
-10,312
| Closed | -$210K | – | 3212 |
|
|
2015
Q4 | $210K | Buy |
+10,312
| New | +$159K | ﹤0.01% | 2445 |
|
John Overdeck's AGTC Position: Q4 2022 in Review
John Overdeck sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 80,397 shares — an estimated $22K sold.
John Overdeck first reported a position in AGTC in Q4 2015 and held it in 21 quarters. The position peaked at $914K in Q3 2018. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- John Overdeck reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- John Overdeck sold 80,397 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $22K.
- John Overdeck first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 21 quarters.
- John Overdeck's Applied Genetic Technologies Corporation position peaked at $914K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.